Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV

INTRODUCTION: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an effective way of protecting individuals from severe coronavirus disease 2019 (COVID-19). However, immune responses to vaccination vary considerably. This study dynamically assessed the neut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Li, Jianhua, Zhang, Wenhui, Liu, Shourong, Miao, Liangbin, Li, Zhaoyi, Fu, Ai, Bao, Jianfeng, Huang, Lili, Zheng, Liping, Li, Er, Zhang, Yanjun, Yu, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017959/
https://www.ncbi.nlm.nih.gov/pubmed/36936952
http://dx.doi.org/10.3389/fimmu.2023.1152695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017959/
https://www.ncbi.nlm.nih.gov/pubmed/36936952
http://dx.doi.org/10.3389/fimmu.2023.1152695

Ejemplares similares